Yariv Mazor

Person

Gaithersburg, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody molecules and conjugates
- Patent number 12,065,496
- Issue date Aug 20, 2024
- Astrazeneca AB
- Frank Irvine Comer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number RE49908
- Issue date Apr 9, 2024
- MedImmune, LLC
- Srinath Kasturirangan
Information Patent Grant
Bispecific PD-1 and TIGIT binding proteins and uses thereof
- Patent number 11,939,382
- Issue date Mar 26, 2024
- MedImmune, LLC
- Yariv Mazor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number 11,279,759
- Issue date Mar 22, 2022
- MedImmune, LLC
- Srinath Kasturirangan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number 10,457,732
- Issue date Oct 29, 2019
- MedImmune, LLC
- Srinath Kasturirangan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified polypeptides for bispecific antibody scaffolds
- Patent number 9,527,927
- Issue date Dec 27, 2016
- MedImmune, LLC
- Partha S. Chowdhury
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Optimized CD3 Antigen Binding Domains
- Publication number 20250019438
- Publication date Jan 16, 2025
- Medimmune, LLC
- Yariv MAZOR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Engineered Antibodies
- Publication number 20250011426
- Publication date Jan 9, 2025
- Medimmune, LLC
- Yariv MAZOR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Engineered Antibodies
- Publication number 20240417467
- Publication date Dec 19, 2024
- Medimmune, LLC
- Yariv MAZOR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Trispecific Engineered Antibodies
- Publication number 20240417468
- Publication date Dec 19, 2024
- Medimmune, LLC
- Yariv MAZOR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES AND CONJUGATES
- Publication number 20240360226
- Publication date Oct 31, 2024
- AstraZeneca AB
- Frank Irvine COMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEREOF
- Publication number 20240287183
- Publication date Aug 29, 2024
- Medimmune, LLC
- Yariv MAZOR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES AND CONJUGATES
- Publication number 20230183358
- Publication date Jun 15, 2023
- AstraZeneca AB
- Frank Irvine COMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEROF
- Publication number 20220411509
- Publication date Dec 29, 2022
- Medimmune, LLC
- Yariv MAZOR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY TARGETING PD-1 AND TIM-3
- Publication number 20220332818
- Publication date Oct 20, 2022
- Medimmune, LLC
- Kristen POLLIZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20220251204
- Publication date Aug 11, 2022
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20200172622
- Publication date Jun 4, 2020
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20180022807
- Publication date Jan 25, 2018
- Medimmune, LLC
- Srinath KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED POLYPEPTIDES FOR BISPECIFIC ANTIBODY SCAFFOLDS
- Publication number 20140348839
- Publication date Nov 27, 2014
- Partha S. Chowdhury
- C07 - ORGANIC CHEMISTRY

Yariv Mazor

Person

Patents Grantslast 30 patents

Antibody molecules and conjugates

Bispecific binding proteins and uses thereof

Bispecific PD-1 and TIGIT binding proteins and uses thereof

Bispecific binding proteins and uses thereof

Bispecific binding proteins and uses thereof

Modified polypeptides for bispecific antibody scaffolds

Patents Applicationslast 30 patents

Optimized CD3 Antigen Binding Domains

Engineered Antibodies

Bispecific Engineered Antibodies

Trispecific Engineered Antibodies

ANTIBODY MOLECULES AND CONJUGATES

BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEREOF

ANTIBODY MOLECULES AND CONJUGATES

BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEROF

BISPECIFIC ANTIBODY TARGETING PD-1 AND TIM-3

BISPECIFIC BINDING PROTEINS AND USES THEREOF

BISPECIFIC BINDING PROTEINS AND USES THEREOF

BISPECIFIC BINDING PROTEINS AND USES THEREOF

MODIFIED POLYPEPTIDES FOR BISPECIFIC ANTIBODY SCAFFOLDS